Subacute TGFβ Expression Drives Inflammation, Goblet Cell Hyperplasia, and Pulmonary Function Abnormalities in Mice with Effects Dependent on CFTR Function

Subacute TGFβ Expression Drives Inflammation, Goblet Cell Hyperplasia, and Pulmonary Function... Background. Cystic fibrosis (CF) produces variable lung disease phenotypes that are in part independent of CFTR genotype. Transforming growth factor beta (TGFβ) is the best described genetic modifier of the CF phenotype, but its mechanism of action is unknown. We hypothesized that TGFβ is sufficient to drive pathognomonic features of CF lung disease in vivo and that CFTR deficiency enhances susceptibility to pathologic TGFβ effects.Methods. A CF mouse model and littermate controls were exposed intratracheally to an adenoviral vector containing the TGFβ1 cDNA (Ad-TGFβ), empty vector, or PBS only. Studies were performed one week after treatment, including lung mechanics, collection of bronchoalveolar lavage fluid (BALF), and analysis of lung histology, RNA, and protein. Results. CF and non-CF mice showed similar weight loss, inflammation, goblet cell hyperplasia, and Smad pathway activation after Ad-TGFβ treatment. Ad-TGFβ produced greater abnormalities in lung mechanics in CF vs control mice, which was uniquely associated with induction of PI3K and MAPK signaling. CFTR transcripts were reduced and ENaC transcripts were increased in CF and non-CF mice, while the goblet cell transcription factors FoxA3 and SPDEF were increased in non-CF but not CF mice following Ad-TGFβ treatment.Conclusion. Pulmonary TGFβ1 expression was sufficient to produce pulmonary remodeling and abnormalities in lung mechanics that were associated with both shared and unique cell signaling pathway activation in CF and non-CF mice. These results highlight the multi-functional impact of TGFβ on pulmonary pathology in vivo and identify cellular response differences that may impact CF lung pathology. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Lung Cellular and Molecular Physiology The American Physiological Society

Subacute TGFβ Expression Drives Inflammation, Goblet Cell Hyperplasia, and Pulmonary Function Abnormalities in Mice with Effects Dependent on CFTR Function

Loading next page...
 
/lp/aps/subacute-tgf-expression-drives-inflammation-goblet-cell-hyperplasia-6zFKZ0D0EK
ISSN
1040-0605
eISSN
1522-1504
D.O.I.
10.1152/ajplung.00530.2017
Publisher site
See Article on Publisher Site

Abstract

Background. Cystic fibrosis (CF) produces variable lung disease phenotypes that are in part independent of CFTR genotype. Transforming growth factor beta (TGFβ) is the best described genetic modifier of the CF phenotype, but its mechanism of action is unknown. We hypothesized that TGFβ is sufficient to drive pathognomonic features of CF lung disease in vivo and that CFTR deficiency enhances susceptibility to pathologic TGFβ effects.Methods. A CF mouse model and littermate controls were exposed intratracheally to an adenoviral vector containing the TGFβ1 cDNA (Ad-TGFβ), empty vector, or PBS only. Studies were performed one week after treatment, including lung mechanics, collection of bronchoalveolar lavage fluid (BALF), and analysis of lung histology, RNA, and protein. Results. CF and non-CF mice showed similar weight loss, inflammation, goblet cell hyperplasia, and Smad pathway activation after Ad-TGFβ treatment. Ad-TGFβ produced greater abnormalities in lung mechanics in CF vs control mice, which was uniquely associated with induction of PI3K and MAPK signaling. CFTR transcripts were reduced and ENaC transcripts were increased in CF and non-CF mice, while the goblet cell transcription factors FoxA3 and SPDEF were increased in non-CF but not CF mice following Ad-TGFβ treatment.Conclusion. Pulmonary TGFβ1 expression was sufficient to produce pulmonary remodeling and abnormalities in lung mechanics that were associated with both shared and unique cell signaling pathway activation in CF and non-CF mice. These results highlight the multi-functional impact of TGFβ on pulmonary pathology in vivo and identify cellular response differences that may impact CF lung pathology.

Journal

AJP - Lung Cellular and Molecular PhysiologyThe American Physiological Society

Published: Dec 13, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off